• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲酰肽受体 1(FPR1)抑制肠道肿瘤发生。

Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis.

机构信息

Centre de Recherche des Cordeliers, Equipe Labellisée Par la Ligue Contre le Cancer, Université Paris Cité, Sorbonne Université, Inserm U1138, Institut Universitaire de France, Paris, France.

Metabolomics and Cell Biology Platforms, Villejuif, France.

出版信息

Oncoimmunology. 2023 Jul 21;12(1):2237354. doi: 10.1080/2162402X.2023.2237354. eCollection 2023.

DOI:10.1080/2162402X.2023.2237354
PMID:37492227
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10364666/
Abstract

Formyl peptide receptor-1 (FPR1) is a pattern recognition receptor that is mostly expressed by myeloid cells. In patients with colorectal cancer (CRC), a loss-of-function polymorphism (rs867228) in the gene coding for FPR1 has been associated with reduced responses to chemotherapy or chemoradiotherapy. Moreover, rs867228 is associated with accelerated esophageal and colorectal carcinogenesis. Here, we show that dendritic cells from mice exhibit reduced migration in response to chemotherapy-treated CRC cells. Moreover, mice are particularly susceptible to chronic ulcerative colitis and colorectal oncogenesis induced by the mutagen azoxymethane followed by oral dextran sodium sulfate, a detergent that induces colitis. These experiments were performed after initial co-housing of mice and wild-type controls, precluding major Fpr1-driven differences in the microbiota. Pharmacological inhibition of Fpr1 by cyclosporin H also tended to increase intestinal oncogenesis in mice bearing the mutation, and this effect was reversed by the anti-inflammatory drug sulindac. We conclude that defective FPR1 signaling favors intestinal tumorigenesis through the modulation of the innate inflammatory/immune response.

摘要

甲酰肽受体 1(FPR1)是一种模式识别受体,主要由髓样细胞表达。在结直肠癌(CRC)患者中,编码 FPR1 的基因中的功能丧失性多态性(rs867228)与对化疗或放化疗的反应降低有关。此外,rs867228与食管和结直肠癌的加速发生有关。在这里,我们表明,对化疗处理的 CRC 细胞的反应中, 小鼠的树突状细胞的迁移减少。此外, 小鼠特别容易受到诱变剂氧化偶氮甲烷(azoxymethane)诱导的慢性溃疡性结肠炎和结直肠肿瘤发生的影响,随后是口服葡聚糖硫酸钠(dextran sodium sulfate),这是一种诱导结肠炎的清洁剂。这些实验是在 小鼠和野生型对照最初共同饲养之后进行的,排除了主要由 Fpr1 驱动的微生物群差异。环孢素 H 对 Fpr1 的药理学抑制也倾向于增加携带 突变的小鼠的肠道肿瘤发生,而这种作用被抗炎药舒林达逆转。我们得出结论,FPR1 信号传导的缺陷通过调节先天炎症/免疫反应有利于肠道肿瘤发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/d99a8d487af2/KONI_A_2237354_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/078b619aa1c9/KONI_A_2237354_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/fe116ce9edd9/KONI_A_2237354_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/321d6e1bb37a/KONI_A_2237354_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/e904b25f3da6/KONI_A_2237354_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/d99a8d487af2/KONI_A_2237354_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/078b619aa1c9/KONI_A_2237354_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/fe116ce9edd9/KONI_A_2237354_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/321d6e1bb37a/KONI_A_2237354_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/e904b25f3da6/KONI_A_2237354_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8256/10364666/d99a8d487af2/KONI_A_2237354_F0005_OC.jpg

相似文献

1
Formyl peptide receptor-1 (FPR1) represses intestinal oncogenesis.甲酰肽受体 1(FPR1)抑制肠道肿瘤发生。
Oncoimmunology. 2023 Jul 21;12(1):2237354. doi: 10.1080/2162402X.2023.2237354. eCollection 2023.
2
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency.TLR3 配体在 FPR1 缺陷的情况下重建化疗反应。
Cancer Discov. 2021 Feb;11(2):408-423. doi: 10.1158/2159-8290.CD-20-0465. Epub 2020 Oct 12.
3
Formyl peptide receptor 1 signalling promotes experimental colitis in mice.甲酰肽受体 1 信号促进实验性结肠炎小鼠模型的发病。
Pharmacol Res. 2019 Mar;141:591-601. doi: 10.1016/j.phrs.2019.01.041. Epub 2019 Jan 31.
4
An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1).局部晚期直肠癌预后不良的独立预测因子:甲酰肽受体 1(FPR1)中的 rs867228。
Oncoimmunology. 2021 May 14;10(1):1926074. doi: 10.1080/2162402X.2021.1926074.
5
The Expression of Formyl Peptide Receptor 1 is Correlated with Tumor Invasion of Human Colorectal Cancer.形式肽受体 1 的表达与人类结直肠癌的肿瘤侵袭相关。
Sci Rep. 2017 Jul 19;7(1):5918. doi: 10.1038/s41598-017-06368-9.
6
No impact of cancer and plague-relevant polymorphisms on COVID-19.癌症和瘟疫相关多态性对 COVID-19 无影响。
Oncoimmunology. 2020 Dec 8;9(1):1857112. doi: 10.1080/2162402X.2020.1857112.
7
V101L of human formyl peptide receptor 1 (FPR1) increases receptor affinity and augments the antagonism mediated by cyclosporins.V101L 突变的人源形式趋化因子受体 1(FPR1)增加了受体亲和力,并增强了环孢素介导的拮抗作用。
Biochem J. 2013 Apr 15;451(2):245-55. doi: 10.1042/BJ20121839.
8
Neutrophil infiltration of the colon is independent of the FPR1 yet FPR1 deficient mice show differential susceptibilities to acute versus chronic induced colitis.中性粒细胞浸润结肠与 FPR1 无关,但 FPR1 缺陷小鼠对急性和慢性诱导结肠炎的易感性不同。
Dig Dis Sci. 2012 Jul;57(7):1802-12. doi: 10.1007/s10620-012-2082-y. Epub 2012 Mar 2.
9
Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.形式肽受体 1(FPR1)多态性降低了局部晚期直肠癌新辅助放化疗(CCRT)治疗后的治疗效果和抗肿瘤免疫。
Cancer Immunol Immunother. 2021 Oct;70(10):2937-2950. doi: 10.1007/s00262-021-02894-8. Epub 2021 Mar 13.
10
TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.TRIB3 通过与β-catenin 和 TCF4 相互作用来增加结直肠癌细胞干细胞的干细胞特征和肿瘤发生。
Gastroenterology. 2019 Feb;156(3):708-721.e15. doi: 10.1053/j.gastro.2018.10.031. Epub 2018 Oct 24.

引用本文的文献

1
Bioactive Compounds as Modulators of N-Formyl Peptide Signaling in Chronic Diseases.生物活性化合物作为慢性疾病中N-甲酰肽信号传导的调节剂
Molecules. 2025 Jul 16;30(14):2981. doi: 10.3390/molecules30142981.
2
The neutrophil extracellular trap-related gene FPR1 (formyl peptide receptor 1) as a potential prognostic and therapeutic target in osteosarcoma.中性粒细胞胞外诱捕网相关基因FPR1(甲酰肽受体1)作为骨肉瘤潜在的预后和治疗靶点。
BMC Musculoskelet Disord. 2025 Mar 31;26(1):309. doi: 10.1186/s12891-024-08231-1.
3
Targeting immunogenic cell stress and death for cancer therapy.

本文引用的文献

1
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancer.FPR1 上的 rs867228 加速了管腔 B 型乳腺癌的发生。
Oncoimmunology. 2023 Mar 21;12(1):2189823. doi: 10.1080/2162402X.2023.2189823. eCollection 2023.
2
Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN.2020年和2040年全球结直肠癌负担:来自全球癌症负担(GLOBOCAN)的发病率和死亡率估计
Gut. 2023 Feb;72(2):338-344. doi: 10.1136/gutjnl-2022-327736. Epub 2022 Sep 8.
3
Critical role of FPR1 in splenocyte migration into brain to worsen inflammation and ischemic brain injury in mice.
针对免疫原性细胞应激和死亡的癌症治疗。
Nat Rev Drug Discov. 2024 Jun;23(6):445-460. doi: 10.1038/s41573-024-00920-9. Epub 2024 Apr 15.
4
Effect of Cyclosporin H on ischemic injury and neutrophil infiltration in cerebral infarct model of rats via PET imaging.环孢素 H 通过正电子发射断层扫描成像对大鼠脑梗死模型缺血性损伤和中性粒细胞浸润的影响。
Ann Nucl Med. 2024 May;38(5):337-349. doi: 10.1007/s12149-024-01900-0. Epub 2024 Feb 15.
5
Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity.单细胞分析结直肠癌浸润 T 淋巴细胞:特异性的困境。
Oncoimmunology. 2024 Jan 4;13(1):2300520. doi: 10.1080/2162402X.2023.2300520. eCollection 2024.
FPR1 在脾细胞向大脑迁移中起关键作用,加重了小鼠的炎症和缺血性脑损伤。
Theranostics. 2022 Mar 21;12(7):3024-3044. doi: 10.7150/thno.57218. eCollection 2022.
4
Improved Swiss-rolling method for histological analyses of colon tissue.用于结肠组织组织学分析的改良瑞士卷法
MethodsX. 2022 Feb 9;9:101630. doi: 10.1016/j.mex.2022.101630. eCollection 2022.
5
Molecular recognition of formylpeptides and diverse agonists by the formylpeptide receptors FPR1 and FPR2.甲酰肽受体 FPR1 和 FPR2 对甲酰肽和多种激动剂的分子识别。
Nat Commun. 2022 Feb 25;13(1):1054. doi: 10.1038/s41467-022-28586-0.
6
administration exacerbated the development of colitis-associated colorectal cancer in mice.给药加剧了小鼠结肠炎相关结直肠癌的发展。
J Cancer. 2022 Jan 1;13(1):124-133. doi: 10.7150/jca.63578. eCollection 2022.
7
An independent predictor of poor prognosis in locally advanced rectal cancer: rs867228 in formyl peptide receptor 1 (FPR1).局部晚期直肠癌预后不良的独立预测因子:甲酰肽受体 1(FPR1)中的 rs867228。
Oncoimmunology. 2021 May 14;10(1):1926074. doi: 10.1080/2162402X.2021.1926074.
8
Knockout of Formyl Peptide Receptor-1 Attenuates Cigarette Smoke-Induced Airway Inflammation in Mice.甲酰肽受体-1基因敲除减轻香烟烟雾诱导的小鼠气道炎症
Front Pharmacol. 2021 Apr 26;12:632225. doi: 10.3389/fphar.2021.632225. eCollection 2021.
9
Inhibitory Effects of Breast Milk-Derived Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model.母乳源 Probio-M9 通过恢复小鼠模型肠道微生物群抑制结肠炎相关癌变的作用。
Nutrients. 2021 Mar 30;13(4):1143. doi: 10.3390/nu13041143.
10
Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer.形式肽受体 1(FPR1)多态性降低了局部晚期直肠癌新辅助放化疗(CCRT)治疗后的治疗效果和抗肿瘤免疫。
Cancer Immunol Immunother. 2021 Oct;70(10):2937-2950. doi: 10.1007/s00262-021-02894-8. Epub 2021 Mar 13.